Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―

Background: Circulating soluble neprilysin (sNEP) predicts outcome in heart failure (HF) patients with reduced ejection fraction (EF), but not in those with preserved EF. We examined sNEP in patients with hypertrophic cardiomyopathy (HCM), and their correlations with other biomarkers, cardiac functi...

詳細記述

保存先:
書誌詳細
出版年:Circ Rep
主要な著者: Yoshihisa, Akiomi, Yokokawa, Tetsuro, Ichijo, Yasuhiro, Kimishima, Yusuke, Kanno, Yuki, Misaka, Tomofumi, Sato, Takamasa, Oikawa, Masayoshi, Kobayashi, Atsushi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Takeishi, Yasuchika
フォーマット: Artigo
言語:Inglês
出版事項: The Japanese Circulation Society 2019
主題:
Original article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889477/
https://ncbi.nlm.nih.gov/pubmed/33693148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0034
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料